ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-2.45%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$364M
AUM Growth
+$364M
(-1.2%)
Cap. Flow
+$5.68M
Cap. Flow
% of AUM
1.56%
Top 10 Holdings %
Top 10 Hldgs %
44.42%
Holding
83
New
22
Increased
23
Reduced
12
Closed
25
Top Buys
| 1 |
Cigna
CI
|
$17M |
| 2 |
Icon
ICLR
|
$16.4M |
| 3 |
Thermo Fisher Scientific
TMO
|
$15M |
| 4 |
Tenet Healthcare
THC
|
$14.6M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$9.8M |
Top Sells
| 1 |
OrthoPediatrics
KIDS
|
$19.3M |
| 2 |
AdaptHealth
AHCO
|
$14.7M |
| 3 |
Sanofi
SNY
|
$13.5M |
| 4 |
Becton Dickinson
BDX
|
$13.2M |
| 5 |
CVS Health
CVS
|
$12.6M |
Sector Composition
| 1 | Healthcare | 80.17% |
| 2 | Industrials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Johnson & Johnson
JNJ
$429B
| $5.44M | 1.49% |
32,998
+4,144
| +14% | +$683K |
|
27
Avantor
AVTR
$8.74B
| $5.41M | 1.49% |
152,395
-88,621
| -37% | -$3.15M |
|
28
Cencora
COR
$57.2B
| $4.78M | 1.31% |
41,729
-20,993
| -33% | -$2.4M |
|
29
Elevance Health
ELV
$72.4B
| $4.56M | 1.25% |
11,941
-19,857
| -62% | -$7.58M |
|
30
Fate Therapeutics
FATE
$115M
| $4.43M | 1.22% |
51,031
+37,599
| +280% | +$3.26M |
|
31
ARS Pharmaceuticals
SPRY
$1.08B
| $4.3M | 1.18% |
+139,124
| New | +$4.3M |
|
|
CALT
32
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $4.25M | 1.17% |
144,393
+2,070
| +1% | +$61K |
|
33
Iovance Biotherapeutics
IOVA
$800M
| $4.17M | 1.15% |
160,362
-150,287
| -48% | -$3.91M |
|
34
Cartesian Therapeutics
RNAC
$267M
| $3.88M | 1.07% |
30,898
+508
| +2% | +$63.7K |
|
35
Praxis Precision Medicines
PRAX
$980M
| $3.65M | 1% |
+13,304
| New | +$3.65M |
|
|
ALBO
36
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $3.64M | 1% |
103,512
+337
| +0.3% | +$11.9K |
|
|
MDVL
37
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $3.58M | 0.98% |
5,844
+1,249
| +27% | +$765K |
|
38
Regeneron Pharmaceuticals
REGN
$59.8B
| $3.11M | 0.85% |
+5,563
| New | +$3.11M |
|
39
Teleflex
TFX
$5.57B
| $3.01M | 0.83% |
+7,501
| New | +$3.01M |
|
40
Owens & Minor
OMI
$423M
| $2.84M | 0.78% |
66,989
+2,977
| +5% | +$126K |
|
|
MREO
41
Mereo BioPharma
MREO
$275M
| $2.4M | 0.66% |
756,915
-582,920
| -44% | -$1.85M |
|
42
Sarepta Therapeutics
SRPT
$1.98B
| $2.23M | 0.61% |
+28,625
| New | +$2.23M |
|
43
Immunic
IMUX
$79.4M
| $2.17M | 0.6% |
177,148
+45,352
| +34% | +$556K |
|
|
RGLS
44
DELISTED
Regulus Therapeutics
RGLS
| $2.12M | 0.58% |
260,767
+23,111
| +10% | +$188K |
|
45
Aclaris Therapeutics
ACRS
$223M
| $2.1M | 0.58% |
119,378
-336,007
| -74% | -$5.9M |
|
46
Baxter International
BAX
$12.1B
| $2.02M | 0.55% |
+25,059
| New | +$2.02M |
|
47
Pennant Group
PNTG
$853M
| $1.94M | 0.53% |
+47,475
| New | +$1.94M |
|
48
Forte Biosciences
FBRX
$138M
| $1.79M | 0.49% |
2,135
+1,031
| +93% | +$866K |
|
49
Vertex Pharmaceuticals
VRTX
$102B
| $1.52M | 0.42% |
+7,553
| New | +$1.52M |
|
|
BLU
50
DELISTED
BELLUS Health Inc.
BLU
| $1.26M | 0.35% |
406,537
+92,702
| +30% | +$288K |
|